491 related articles for article (PubMed ID: 35036354)
1. Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank.
Zhou Z; Cong L; Cong X
Front Oncol; 2021; 11():762184. PubMed ID: 35036354
[TBL] [Abstract][Full Text] [Related]
2. Tumor organoid biobank-new platform for medical research.
Xie X; Li X; Song W
Sci Rep; 2023 Feb; 13(1):1819. PubMed ID: 36725963
[TBL] [Abstract][Full Text] [Related]
3. Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research.
Duzagac F; Saorin G; Memeo L; Canzonieri V; Rizzolio F
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578886
[TBL] [Abstract][Full Text] [Related]
4. Living biobank-based cancer organoids: prospects and challenges in cancer research.
Li H; Liu H; Chen K
Cancer Biol Med; 2022 Jul; 19(7):965-82. PubMed ID: 35856555
[TBL] [Abstract][Full Text] [Related]
5. Organoid and Spheroid Tumor Models: Techniques and Applications.
Gunti S; Hoke ATK; Vu KP; London NR
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669619
[TBL] [Abstract][Full Text] [Related]
6. Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine.
Novelli G; Spitalieri P; Murdocca M; Centanini E; Sangiuolo F
Front Cell Dev Biol; 2022; 10():1059579. PubMed ID: 36699015
[TBL] [Abstract][Full Text] [Related]
7. Micro-Engineered Organoid-on-a-Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients.
Zou Z; Lin Z; Wu C; Tan J; Zhang J; Peng Y; Zhang K; Li J; Wu M; Zhang Y
Adv Sci (Weinh); 2023 Sep; 10(27):e2302640. PubMed ID: 37485650
[TBL] [Abstract][Full Text] [Related]
8. Patient-derived cancer organoids for drug screening: Basic technology and clinical application.
Ren X; Chen W; Yang Q; Li X; Xu L
J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived organoid (PDO) platforms to facilitate clinical decision making.
Liu L; Yu L; Li Z; Li W; Huang W
J Transl Med; 2021 Jan; 19(1):40. PubMed ID: 33478472
[TBL] [Abstract][Full Text] [Related]
10. Personalized Cancer Medicine: An Organoid Approach.
Aboulkheyr Es H; Montazeri L; Aref AR; Vosough M; Baharvand H
Trends Biotechnol; 2018 Apr; 36(4):358-371. PubMed ID: 29366522
[TBL] [Abstract][Full Text] [Related]
11. Translational and Clinical Relevance of PDX-Derived Organoid Models in Oncology Drug Discovery and Development.
Kumari R; Xu X; Li HQ
Curr Protoc; 2022 Jul; 2(7):e431. PubMed ID: 35789132
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.
Qu S; Xu R; Yi G; Li Z; Zhang H; Qi S; Huang G
Mol Biomed; 2024 Feb; 5(1):6. PubMed ID: 38342791
[TBL] [Abstract][Full Text] [Related]
13. Tumor organoids for cancer research and personalized medicine.
Yang H; Wang Y; Wang P; Zhang N; Wang P
Cancer Biol Med; 2021 Sep; 19(3):319-32. PubMed ID: 34520134
[TBL] [Abstract][Full Text] [Related]
14. Biobanking of human gut organoids for translational research.
Perrone F; Zilbauer M
Exp Mol Med; 2021 Oct; 53(10):1451-1458. PubMed ID: 34663935
[TBL] [Abstract][Full Text] [Related]
15. Automation of Organoid Cultures: Current Protocols and Applications.
Louey A; Hernández D; Pébay A; Daniszewski M
SLAS Discov; 2021 Oct; 26(9):1138-1147. PubMed ID: 34167363
[TBL] [Abstract][Full Text] [Related]
16. Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine.
Gilazieva Z; Ponomarev A; Rutland C; Rizvanov A; Solovyeva V
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977530
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response.
Piro G; Agostini A; Larghi A; Quero G; Carbone C; Esposito A; Rizzatti G; Attili F; Alfieri S; Costamagna G; Tortora G
Front Med (Lausanne); 2021; 8():793144. PubMed ID: 35004765
[TBL] [Abstract][Full Text] [Related]
18. From organoids to bedside: Advances in modeling, decoding and targeting of colorectal cancer.
Betge J; Jackstadt R
Int J Cancer; 2023 Apr; 152(7):1304-1313. PubMed ID: 36121667
[TBL] [Abstract][Full Text] [Related]
19. Revolutionising immune research with organoid-based co-culture and chip systems.
Papp D; Korcsmaros T; Hautefort I
Clin Exp Immunol; 2024 Jan; ():. PubMed ID: 38280212
[TBL] [Abstract][Full Text] [Related]
20. Organoid technology in female reproductive biomedicine.
Heidari-Khoei H; Esfandiari F; Hajari MA; Ghorbaninejad Z; Piryaei A; Baharvand H
Reprod Biol Endocrinol; 2020 Jun; 18(1):64. PubMed ID: 32552764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
